keliximab keliximab keliximab is a monoclonal antibody for the treatment of severe chronic asthma. it suppresses the immune reaction by binding to white blood cells via the protein cd4. the drug is a chimeric antibody from macaca irus and homo sapiens. keliximabmonoclonal antibodytypewhole antibodysourcechimeric (primate/human)targetcd4clinical dataroutes ofadministrationintravenousatc codenoneidentifierscas number174722-30-6 ychemspidernoneunii62l6lcf5eu ny (what is this?) (verify)